Sort   by:  
 Page size 
UnknownDenfivontinib Activates Effector T Cells Through the NLRP3 Inflammasome, Yielding Potent Anticancer Effects by Combination with Pembrolizumab.
Not available
S-EPMC11876964 | biostudies-literature
UnknownPhysical Activity, Alzheimer Plasma Biomarkers, and Cognition.
Not available
S-EPMC11883494 | biostudies-literature
UnknownCrystal structure of rhodopsin bound to arrestin by femtosecond X-ray laser.
Not available
S-EPMC4521999 | biostudies-literature
UnknownTemporal Dynamics and Biological Variability of Alzheimer Biomarkers.
Not available
S-EPMC11833660 | biostudies-literature
UnknownThe third Intensive Care Bundle with Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT3): an international, stepped wedge cluster randomised controlled trial.
Not available
S-EPMC10401723 | biostudies-literature
UnknownSurgical outcomes from haematoma evacuation for intracerebral haemorrhage in the INTERACT3 study.
Not available
S-EPMC12414919 | biostudies-literature
UnknownObservation of charge-parity symmetry breaking in baryon decays.
Not available
S-EPMC12310544 | biostudies-literature
UnknownBurden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.
Not available
S-EPMC12535840 | biostudies-literature
UnknownGlobal age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950-2023: a demographic analysis for the Global Burden of Disease Study 2023.
Not available
S-EPMC12535839 | biostudies-literature
UnknownGlobal burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.
Not available
S-EPMC12535838 | biostudies-literature
Sort   by:  
 Page size